Loading organizations...
§ Private Profile · Hanover, Niedersachsen, Germany
Medical device company develops implantable micro-sensors for continuous intraocular pressure monitoring in glaucoma patients.
Implandata Ophthalmic Products, headquartered in Hannover, Germany, specializes in developing the EYEMATE system, an implantable micro-sensor designed for continuous intraocular pressure monitoring in glaucoma patients under normal life conditions. This innovative CE-marked system, which also holds FDA Breakthrough Device Designation, significantly enhances remote disease management and facilitates personalized treatment strategies to effectively prevent vision loss. As a privately held medical device company, Implandata successfully secured a mid-single digit million Euro first closing for its Series C funding round in 2018. Prominent investors in the company include Heidelberg Engineering, Occident Group AG, and NKB GmbH. Founded in 2010 by Max G. Ostermeier, Implandata recently strengthened its governance by appointing Dr. Adrienne Graves and Jan Willem de Cler to its Board of Directors, with de Cler assuming the role of Chairman.
Implandata Ophthalmic Products has raised $4.7M across 3 funding rounds.
Implandata Ophthalmic Products has raised $4.7M in total across 3 funding rounds.
Implandata Ophthalmic Products has raised $4.7M across 3 funding rounds. Most recently, it raised $2.0M Series A Extension in August 2012.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 30, 2012 | $2M Series A Plus | Enjoyventure, Peppermint Venture Partners | KFW | Announced |
| Jan 31, 2012 | $1.8M Series A | — | Hannover Beteiligungsfonds, High Tech Grunderfonds | Announced |
| Jun 21, 2010 | $870K Venture Round | — | Hannover Innovations Fonds, High Tech Grunderfonds | Announced |
Implandata Ophthalmic Products has raised $4.7M in total across 3 funding rounds.
Implandata Ophthalmic Products's investors include EnjoyVenture, Peppermint Venture Partners, KfW, Hannover Beteiligungsfonds, High-Tech Grunderfonds, Hannover Innovations Fonds.